India draws clearer patent boundaries for life sciences in court-driven guidelines
India's draft pharmaceutical and biotechnology patent guidelines incorporate recent court rulings, giving life-sciences companies clearer guidance on patentability, evidentiary requirements, diagnostic inventions and the scope of permissible claims.India is giving pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article